IL122482A - Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby - Google Patents

Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby

Info

Publication number
IL122482A
IL122482A IL12248296A IL12248296A IL122482A IL 122482 A IL122482 A IL 122482A IL 12248296 A IL12248296 A IL 12248296A IL 12248296 A IL12248296 A IL 12248296A IL 122482 A IL122482 A IL 122482A
Authority
IL
Israel
Prior art keywords
methods
compositions obtained
foamed glass
stably incorporating
dry foamed
Prior art date
Application number
IL12248296A
Other languages
English (en)
Other versions
IL122482A0 (en
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of IL122482A0 publication Critical patent/IL122482A0/xx
Publication of IL122482A publication Critical patent/IL122482A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
IL12248296A 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby IL122482A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (2)

Publication Number Publication Date
IL122482A0 IL122482A0 (en) 1998-06-15
IL122482A true IL122482A (en) 1999-10-28

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12248296A IL122482A (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby

Country Status (22)

Country Link
EP (1) EP0831790B1 (de)
JP (1) JP4502406B2 (de)
KR (1) KR19990022710A (de)
CN (1) CN1245957C (de)
AP (1) AP852A (de)
AT (1) ATE239451T1 (de)
AU (1) AU713599B2 (de)
BR (1) BR9609188A (de)
CA (1) CA2223438C (de)
CZ (1) CZ391297A3 (de)
DE (1) DE69628007T2 (de)
DK (1) DK0831790T3 (de)
ES (1) ES2194992T3 (de)
HU (1) HUP9901716A3 (de)
IL (1) IL122482A (de)
MX (1) MX9709716A (de)
NO (1) NO975773L (de)
NZ (1) NZ309841A (de)
PL (1) PL184823B1 (de)
PT (1) PT831790E (de)
SK (1) SK167597A3 (de)
WO (1) WO1996040077A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679088B1 (de) 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonale abgabe von aktiven fragmenten des parathormons
ATE416755T1 (de) 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
DE69530196T2 (de) 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
EP1032647B1 (de) * 1997-11-26 2006-03-29 Universal Preservation Technologies, Inc. Konservierung empfindlicher biologischer proben durch verglasung
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
AU2945199A (en) * 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
ES2290028T3 (es) * 1999-05-04 2008-02-16 Anhydro Limited Metodo para la conservacion de virus y micoplasma.
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PL203804B1 (pl) * 2000-06-27 2009-11-30 Hoffmann La Roche Sposób wytwarzania kompozycji farmaceutycznej w postaci spoistej, płytkowej, piankowej, gąbczastej lub ciastowatej struktury i kompozycja farmaceutyczna otrzymana tym sposobem
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
JP2005508992A (ja) * 2001-11-09 2005-04-07 セントカー・インコーポレーテツド 凍結乾燥されたモノクローナル抗体組成物
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
CA2503946C (en) * 2002-11-01 2016-08-16 Glaxosmithkline Biologicals S.A. Drying process
EP1428526A1 (de) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Zusammensetzung zur schnellen Freisetzung von lipophilen Stoffen
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
DE602005016402D1 (de) 2004-05-24 2009-10-15 Genvault Corp Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
EP1750760B1 (de) 2004-06-02 2017-06-28 Universal Stabilization Technologies, Inc. Konservierung mittels verdampfung
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP2117354B1 (de) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. Trockenes nahrungsmittel mit lebendem probiotikum
CA2694083A1 (en) 2007-07-26 2009-01-29 Sanofi Pasteur Limited Antigen-adjuvant compositions and methods
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
WO2010111565A2 (en) 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
EP2435554B1 (de) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stabile trockenpulverzusammensetzung mit biologisch aktiven mikroorganismen und/oder bioaktiven materialien sowie herstellungsverfahren dafür
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
PL2529004T3 (pl) 2010-01-28 2017-12-29 Advanced Bionutrition Corporation Sucha szklista kompozycja zawierająca bioaktywny materiał
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
AR082682A1 (es) 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
CN107625958A (zh) * 2011-05-17 2018-01-26 索利吉尼克斯公司 热稳定性疫苗组合物及其制备方法
CN107233569B (zh) 2011-10-25 2021-08-31 普罗西纳生物科学有限公司 抗体制剂和方法
GB2498774A (en) * 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
ES2818569T3 (es) * 2015-09-09 2021-04-13 Drawbridge Health Inc Métodos para la recopilación, estabilización y conservación de muestras
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
GB2590814B (en) 2017-01-10 2021-11-03 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN118086244B (zh) * 2023-08-18 2024-08-06 北京中检葆泰生物技术有限公司 一种乳源碱性磷酸酶标准品的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
JPS6115830A (ja) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− 制酸剤組成物およびその製造方法
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
JP3016096B2 (ja) * 1989-05-01 2000-03-06 バクスター インターナショナル インコーポレーテッド 有益な薬剤から成る組成物および制御された溶解により該組成物を投与する方法
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
DK0615438T3 (da) * 1991-12-05 1996-11-11 Mallinckrodt Veterinary Inc En carbohydratglasmatrix til langvarig frigivelse af et terapeutisk middel
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
EP0760680A1 (de) * 1994-05-27 1997-03-12 Farmarc Nederland Bv Pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
CA2223438A1 (en) 1996-12-19
CN1193908A (zh) 1998-09-23
IL122482A0 (en) 1998-06-15
PL323902A1 (en) 1998-04-27
KR19990022710A (ko) 1999-03-25
MX9709716A (es) 1998-03-31
EP0831790A2 (de) 1998-04-01
AP852A (en) 2000-06-16
HUP9901716A2 (hu) 1999-09-28
WO1996040077A3 (en) 1997-01-23
BR9609188A (pt) 1999-05-11
PT831790E (pt) 2003-07-31
ATE239451T1 (de) 2003-05-15
ES2194992T3 (es) 2003-12-01
SK167597A3 (en) 1998-10-07
NO975773L (no) 1998-02-03
AU713599B2 (en) 1999-12-09
JPH11506467A (ja) 1999-06-08
NZ309841A (en) 1999-10-28
PL184823B1 (pl) 2002-12-31
DE69628007D1 (de) 2003-06-12
JP4502406B2 (ja) 2010-07-14
HUP9901716A3 (en) 2000-04-28
WO1996040077A2 (en) 1996-12-19
AU6009896A (en) 1996-12-30
DE69628007T2 (de) 2003-11-27
AP9701151A0 (en) 1998-01-31
DK0831790T3 (da) 2003-09-01
NO975773D0 (no) 1997-12-08
CA2223438C (en) 2008-05-13
EP0831790B1 (de) 2003-05-07
CZ391297A3 (cs) 1998-05-13
CN1245957C (zh) 2006-03-22

Similar Documents

Publication Publication Date Title
AP9701151A0 (en) Methods for stably incorporating substances within dry foamed glass matrices and compositions obtained thereby
AU7378798A (en) Solid porous matrices and methods of making and using the same
AU5590296A (en) Post-foamable foam composition
EP0553843A3 (en) Foamable silicone rubber composition
GB9508691D0 (en) Stable compositions
IL124376A0 (en) Stable avidin composition and method using same
ZA965857B (en) Cable-sheathing composition
HUP9900743A3 (en) Bituminous composition and using them
HU9602086D0 (en) Glass composition
AU5979496A (en) Composition and methods for losing weight
PL322571A1 (en) Deodoising composition
GB2318814B (en) Foamable gel composition
AU2436495A (en) Dry chocolate-flavored beverage mix
HU9600352D0 (en) Bitumenous composition
HU9602087D0 (en) Glass composition
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
EP0848745A4 (de) Schäumende zusammensetzung
ZA965642B (en) Packaged foaming composition
IL120722A (en) Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
HUP9600148A2 (en) Glass composition
GB9526675D0 (en) Bituminous composition and process
PL330820A1 (en) Novel radiopharmaceutic compositions and matrices and their application
AU6392896A (en) In situ blown foams
GB9524918D0 (en) Solid composition
AU1259097A (en) Dry foamable composition and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees